Combined Oral Contraceptives

Introduction to Combined Oral Contraceptives

Combined oral contraceptives, commonly referred to as COCs or simply the pill, are prescription medications taken daily to prevent pregnancy. Each pill contains a combination of two synthetic female hormones: an estrogen (usually ethinyl estradiol) and a progestin (such as levonorgestrel, drospirenone, or norgestimate). These hormones work together to alter the body's natural reproductive cycle.

Introduced decades ago, COCs remain one of the most popular reversible birth control methods used by women worldwide, including across Nigeria. They are typically packaged in monthly cycles of 21 active pills followed by 7 inactive (placebo) reminder pills, or continuous 28-day regimens. Beyond family planning, millions of women rely on COCs to regulate unpredictable menstrual cycles and manage painful periods.

Mechanism of Action

The primary contraceptive effect of COCs relies on three distinct hormonal pathways that block conception from multiple angles.

• Inhibition of Ovulation: The steady intake of synthetic estrogen and progestin suppresses the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This prevents the pituitary gland from releasing follicle-stimulating hormone (FSH) and luteinizing hormone (LH), meaning no dominant follicle matures and ovulation does not occur.
• Cervical Mucus Alteration: Progestin thickens the mucus at the cervix. This creates a strong physical barrier that blocks sperm from entering the upper reproductive tract to reach an egg.
• Endometrial Atrophy: The continuous hormonal influence keeps the lining of the uterus (endometrium) thin and underdeveloped, preventing a fertilized egg from successfully implanting.

Clinical Screening and Medical Eligibility

Before prescribing COCs, a thorough medical history must be taken to ensure the user has no underlying conditions that increase severe health risks. The World Health Organization Medical Eligibility Criteria for Contraceptive Use (WHO MEC) guide these safety assessments.

The most critical risk associated with the estrogen component is venous thromboembolism (blood clots). Therefore, COCs must be avoided in specific patient groups.

1. History of blood clots: Women with deep vein thrombosis or pulmonary embolism should not use COCs.
2. Cardiovascular disease: Active ischemic heart disease, stroke, or severe high blood pressure.
3. Migraines with aura: Women experiencing neurological migraine symptoms face a significantly higher stroke risk if given estrogen.
4. Liver disease: Severe cirrhosis or liver tumors impair hormone metabolism.
5. Breast cancer: Hormo-sensitive malignancies are an absolute contraindication.
6. Smoking over age 35: Combined with heavy cigarette smoking, estrogen greatly multiplies cardiovascular danger.

Initiation, Dosage, and Missed Pill Protocols

Proper pill-taking ensures high contraceptive efficacy. Midwives should teach clients how to start their packs and what actions to take if pills are forgotten.

When a client misses pills, the risk of ovulation increases. Missing one active pill at any time requires taking it as soon as remembered and continuing the pack normally, with no emergency contraception needed. However, missing two or more active pills in a row during the first or second week means taking the most recent missed pill immediately, discarding older forgotten pills, continuing the rest of the pack, and using backup barrier protection or avoiding sex until active pills have been taken for 7 consecutive days.

Anticipating and Managing Side Effects

Many clients experience minor side effects when first starting COCs as their bodies adjust to exogenous hormones. Reassuring clients that these symptoms are typically harmless and often subside after the first two to three months improves continuation rates.

• Unscheduled Spotting or Bleeding: Common in the initial months, especially if pills are missed or taken late. Midwives should reassure the user that her endometrium is simply stabilizing.
• Nausea and Breast Tenderness: Often caused by the estrogen component. Taking pills with food or right before bed can significantly reduce stomach upset.
• Mild Headaches and Mood Changes: Fluctuations in hormone levels can cause minor headaches. Persistent severe headaches, however, require prompt clinical evaluation.
• Weight Changes: Scientific evidence shows that COCs do not cause true clinical obesity, though mild fluid retention or increased appetite can occur in some individuals.

Counseling and Non-Contraceptive Health Benefits

Effective counseling empowers clients by discussing both birth control reliability and the extra medical advantages COCs offer. Midwives should highlight that COCs do not protect against sexually transmitted infections, so dual protection with condoms remains crucial.

Beyond preventing pregnancy, COCs provide substantial therapeutic health benefits:

• Cycle Regularity and Reduced Flow: Bleeding becomes predictable, and blood loss decreases, lowering the incidence of iron-deficiency anemia.
• Pain Relief: Significant reduction in dysmenorrhea (painful cramps) and ovulation pain.
• Hormonal Regulation: Improvement in symptoms related to polycystic ovary syndrome (PCOS) and moderation of hyperandrogenism (such as unwanted facial hair or acne).
• Cancer Risk Reduction: Long-term use offers significant, lasting protection against both endometrial and ovarian cancers.